Adicet Bio
ACET
ACET
88 hedge funds and large institutions have $630M invested in Adicet Bio in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 22 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 81 → 88 (+7)
3.46% more ownership
Funds ownership: 79.52% → 82.99% (+3.5%)
13% less call options, than puts
Call options by funds: $1.76M | Put options by funds: $2.02M
Holders
88
Holding in Top 10
9
Calls
$1.76M
Puts
$2.02M
Top Buyers
| 1 | +$30M | |
| 2 | +$13M | |
| 3 | +$6.09M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$3.92M |
| 5 |
BlackRock
New York
|
+$3.31M |
Top Sellers
| 1 | -$8.1M | |
| 2 | -$6.21M | |
| 3 | -$3.63M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.5M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.62M |